Jorgensen, Roberta A.

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 727

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 720

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 487

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

Tabibian, J. H., Weeding, E., Jorgensen, R. A., Petz, J. L., Keach, J. C., Talwalkar, J. A., & Lindor, K. D. (2013) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 267

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

Harnois, D. M., Angulo, P., Jorgensen, R. A., LaRusso, N. F., & Lindor, K. D. (2001) · American Journal of Gastroenterology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 242

Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

Angulo, P., Batts, K. P., Therneau, T. M., Jorgensen, R. A., Dickson, R. E., & Lindor, K. D. (1999) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 234

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

Angulo, P., Lindor, K. D., Therneau, T. M., Jorgensen, R. A., Malinchoc, M., Kamath, P. S., & Dickson, E. R. (1999) · Liver International

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 203

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Angulo, P., Jorgensen, R. A., Keach, J. C., Dickson, R. E., Smith, C., & Lindor, K. D. (2000) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 179

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid

Joshi, S., Cauch-Dudek, K., Wanless, I. R., Lindor, K. D., Jorgensen, R., Batts, K., & Heathcote, J. E. (2002) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 174

Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival

Gores, G. J., Wiesner, R. H., Dickson, E. R., Zinsmeister, A. R., Jorgensen, R. A., & Langworthy, A. (1989) · Gastroenterology

Liver Disease and TransplantationLiver Diseases and Immunity

Cited by 173

Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis

Lindor, K. D., Jorgensen, R. A., Therneau, T. M., Malinchoc, M., & Dickson, E. R. (1997) · Mayo Clinic Proceedings

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 166

Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?

Crippin, J. S., Lindor, K. D., Jorgensen, R., Kottke, B. A., Harrison, J. M., Murtaugh, P. A., & Dickson, R. E. (1992) · Hepatology

Liver Diseases and ImmunityCholesterol and Lipid Metabolism

Cited by 149

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo‐controlled trial

Zein, C. O., Jorgensen, R. A., Clarke, B., Wenger, D. E., Keach, J. C., Angulo, P., & Lindor, K. D. (2005) · Hepatology

Bone health and osteoporosis researchLiver Diseases and Immunity

Cited by 142

Natural history of pruritus in primary biliary cirrhosis

Talwalkar, J. A., Souto, E., Jorgensen, R. A., & Lindor, K. D. (2003) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 141

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

Angulo, P., Dickson, E. R., Therneau, T. M., Jorgensen, R. A., Smith, C., DeSotel, C. K., Lange, S. M., Anderson, M. L., Mahoney, D. W., & Lindor, K. D. (1999) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 134

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

Momah, N., Silveira, M. G., Jorgensen, R., Sinakos, E., & Lindor, K. D. (2012) · Liver International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 77

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Jorgensen, R. A., Dickson, E. R., Hofmann, A. F., Rossi, S. S., & Lindor, K. D. (1995) · Gut

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 77

A randomized, placebo‐controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H., & Lindor, K. D. (2017) · American Journal of Therapeutics

Liver Diseases and ImmunityFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 64

Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: Results of a pilot study

Levy, C., Harnois, D. M., Angulo, P., Jorgensen, R., & Lindor, K. D. (2005) · Liver International

Bone health and osteoporosis researchLiver Diseases and Immunity

Cited by 62

Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double‐blind controlled trial

Talwalkar, J. A., Donlinger, J. J., Gossard, A. A., Keach, J. C., Jorgensen, R. A., Petz, J. C., & Lindor, K. D. (2006) · Digestive Diseases and Sciences

Liver Diseases and ImmunityFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 54

Varices in early histological stage primary biliary cirrhosis

Ali, A. H., Sinakos, E., Silveira, M. G., Jorgensen, R. A., Angulo, P., & Lindor, K. D. (2011) · Journal of Clinical Gastroenterology

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 50

Effect of Ursodeoxycholic Acid on Serum Lipids of Patients With Primary Biliary Cirrhosis

BALAN, V., DICKSON, E. R., JORGENSEN, R. A., & LINDOR, K. D. (1994) · Mayo Clinic Proceedings

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 48

Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis

Siegel, J. L., Jorgensen, R., Angulo, P., & Lindor, K. D. (2003) · Journal of Clinical Gastroenterology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 40

Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?

Angulo, P., Jorgensen, R. A., & Lindor, K. D. (2001) · The American Journal of Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 39